Trial Profile
Effect of Telmisartan on the post stroke cognitive decline: a randomized open label study
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 13 May 2016
Price :
$35
*
At a glance
- Drugs Telmisartan (Primary) ; Antihypertensives
- Indications Cerebral infarction; Hypertension
- Focus Pharmacodynamics; Therapeutic Use
- 16 Mar 2016 Status changed from not yet recruiting to discontinued.
- 05 Oct 2012 New trial record